1-13 of 13
Su Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 642: TRAF2 mediates sensitivity to immunomodulatory drugs via NF-κB and ERK signaling in myeloma cells

Jiye Liu, Teru Hideshima, Lijie Xing, Su Wang, Wenrong Zhou, Daisuke Ogiya, Kenneth Wen, Yu-Tzu Tai, Yong Cang, Kenneth C. Anderson
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 642.
https://doi.org/10.1158/1538-7445.AM2020-642
Published: 15 August 2020
View article titled, Abstract 642: TRAF2 mediates sensitivity to immunomodulatory drugs via NF-κB and ERK signaling in myeloma cells
Journal Articles

Abstract 2867: MDM2 and MDM4 are therapeutic vulnerabilities in malignant rhabdoid tumors

Thomas P. Howard, Taylor E. Arnoff, Melinda R. Song, Andrew O. Giacomelli, Xiaofeng Wang, Andrew L. Hong, Neekesh V. Dharia, Su Wang, Francisca Vazquez, Minh-Tam Pham, Ann M. Morgan, Franziska Wachter, Gregory H. Bird, Guillaume Kugener, Elaine M. Oberlick, Matthew G. Rees, Hong Tiv, Justin H. Hwang, Katherine H. Walsh, April Cook, John M. Krill-Burger, Aviad Tsherniak, Prafulla C. Gokhale, Peter J. Park, Kimberly Stegmaier, Loren D. Walensky, William C. Hahn, Charles W. Roberts
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2867.
https://doi.org/10.1158/1538-7445.AM2019-2867
Published: 01 July 2019
View article titled, Abstract 2867: MDM2 and MDM4 are therapeutic vulnerabilities in malignant rhabdoid tumors
Journal Articles

MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors

Thomas P. Howard, Taylor E. Arnoff, Melinda R. Song, Andrew O. Giacomelli, Xiaofeng Wang, Andrew L. Hong, Neekesh V. Dharia, Su Wang, Francisca Vazquez, Minh-Tam Pham, Ann M. Morgan, Franziska Wachter, Gregory H. Bird, Guillaume Kugener, Elaine M. Oberlick, Matthew G. Rees, Hong L. Tiv, Justin H. Hwang, Katherine H. Walsh, April Cook, John M. Krill-Burger, Aviad Tsherniak, Prafulla C. Gokhale, Peter J. Park, Kimberly Stegmaier, Loren D. Walensky, William C. Hahn, Charles W.M. Roberts
Journal: Cancer Research
Cancer Res (2019) 79 (9): 2404–2414.
https://doi.org/10.1158/0008-5472.CAN-18-3066
Published: 01 May 2019
View article titled, MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors
Open the PDF for MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors in another window
Includes: Supplementary data
Journal Articles

Abstract 4030A: S-PLEXSM Troponin I assay with fg/mL sensitivity

Anahit Aghvanyan, Louis Gardner, Animesh Shukla, Thomas Miller, Su Wang, Sheldon Grove, Andrew Chow, Jessica Suschak, Sarah Wheeler, Anu Mathew, Martin K. Stengelin, Jacob N. Wohlstadter
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4030A.
https://doi.org/10.1158/1538-7445.AM2017-4030A
Published: 01 July 2017
View article titled, Abstract 4030A: S-PLEX<sup>SM</sup> Troponin I assay with fg/mL sensitivity
Journal Articles

Abstract LB-096: SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation

Xiaofeng Wang, Ryan Lee, Burak Alver, Jeffrey Haswell, Su Wang, Emma Troisi, Bradley Bernstein, Peter Park, Charles Roberts
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): LB-096.
https://doi.org/10.1158/1538-7445.AM2017-LB-096
Published: 01 July 2017
View article titled, Abstract LB-096: SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation
Journal Articles

Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice

David Surguladze, Dhanvanthri Deevi, Nidia Claros, Erik Corcoran, Su Wang, Mary Jane Plym, Yan Wu, Jacqueline Doody, David J. Mauro, Larry Witte, Klaus J. Busam, Bronek Pytowski, Ulrich Rodeck, James R. Tonra
Journal: Cancer Research
Cancer Res (2009) 69 (14): 5643–5647.
https://doi.org/10.1158/0008-5472.CAN-09-0487
Published: 15 July 2009
View article titled, Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
Open the PDF for Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice in another window
Includes: Supplementary data
Journal Articles

Abstract #833: TNF \#945; and IL-1 antagonists alleviate inflammatory skin changes associated with EGFR antibody therapy in mice

David Surguladze, Dhanvanthri Deevi, Su Wang, Nidia Claros, Mary Plym, Yan Wu, Jacqueline Doody, David Mauro, Larry Witte, Klaus Busam, Bronek Pytowski, Ulrich Rodeck, James Tonra
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 833.
Published: 01 May 2009
View article titled, Abstract #833: TNF \#945; and IL-1 antagonists alleviate inflammatory skin changes associated with EGFR antibody therapy in mice
Journal Articles

Abstract #844: Anti-TGF beta receptor II antibody suppresses tumor growth and metastasis through inhibiting TGF beta autocrine stimulation of tumor cells and myeloid cells

Zhaojing Zhong, Desiree Policarpio, Kyla Carroll, Michael Gregory, Rajiv Bassi, Marie Prewette, Su Wang, Jim Tonra, Xenia Jimenez, Jackie Doody, Kris Persaud, Paul Balderes, Dale Ludwig, Larry Witte, Zhenping Zhu, Yan Wu
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 844.
Published: 01 May 2009
View article titled, Abstract #844: Anti-TGF beta receptor II antibody suppresses tumor growth and metastasis through inhibiting TGF beta autocrine stimulation of tumor cells and myeloid cells
Journal Articles

Expression of vascular endothelial growth factor receptor-1 in human tumor arrays

Su Wang, Yan Wu, Daniel Hicklin, James Tonra
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 4100.
Published: 01 May 2007
View article titled, Expression of vascular endothelial growth factor receptor-1 in human tumor arrays
Journal Articles

Inhibition of human osteosarcoma xenograft growth by anti-Platelet derived growth factor receptor alpha antibody, IMC-3G3, alone and in combination with chemotherapy

Dhanvanthri S. Deevi, Leah Lariccia, Su Wang, Christopher Joynes, Philipp Steiner, Skjalg Bruheim, Oystein Fodstad, Francine E. Carrick, James R. Tonra, Nick Loizos
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 877.
Published: 15 April 2006
View article titled, Inhibition of human osteosarcoma xenograft growth by anti-Platelet derived growth factor receptor alpha antibody, IMC-3G3, alone and in combination with chemotherapy
Journal Articles

Overexpression of LTA4H in colon cancer of humans and animal models.

Su Wang, Jihyeung Ju, Peng Wang, Darren Seril, Guangyu Yang, Sandeep Sood, Chung S. Yang, Xiaoxin Chen
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 512.
Published: 01 April 2004
View article titled, Overexpression of LTA4H in colon cancer of humans and animal models.
Journal Articles

Chemoprevention of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch by a cyclooxygenase 2 inhibitor (Celecoxib) and a 5-lipoxygenase inhibitor (Zileuton).

Ning Li, Sandeep Sood, Mingzhu Fang, Su Wang, Chung S. Yang, Xiaoxin Chen
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 546.
Published: 01 April 2004
View article titled, Chemoprevention of 7,12-dimethylbenz[<em>a</em>]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch by a cyclooxygenase 2 inhibitor (Celecoxib) and a 5-lipoxygenase inhibitor (Zileuton).
Journal Articles

Chemoprevention of esophageal adenocarcinoma in a surgical model with rats by a 5-lipoxygenase inhibitor (Zileuton) in synergy with a cyclooxygenase 2 inhibitor (Celecoxib).

Xiaoxin Chen, Su Wang, Nan Wu, Sandeep Sood, Peng Wang, Zhe Jin, Chung S. Yang, Ronald A. Lubet
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 726.
Published: 01 April 2004
View article titled, Chemoprevention of esophageal adenocarcinoma in a surgical model with rats by a 5-lipoxygenase inhibitor (Zileuton) in synergy with a cyclooxygenase 2 inhibitor (Celecoxib).